Royal Caribbean Cruises Ltd vs UnitedHealth Group Inc — how do they compare? Royal Caribbean Cruises Ltd trades at $282 (market cap $75.26B), while UnitedHealth Group Inc trades at $379.61 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 4.4× Royal Caribbean Cruises Ltd's market cap, and UnitedHealth Group Inc pays the higher dividend (2.5%). Which is the better fit depends on your goals — on Pluang, investors hold Royal Caribbean Cruises Ltd for 85 Days and UnitedHealth Group Inc for 97 Days on average.
| RCL | UNH | |
|---|---|---|
Market Cap | $75.26B | $332.96B |
Volume | 1,958,628 | 7,273,749 |
Sector | Consumer Cyclical | Health |
52-Week High | $348.03 | $436.35 |
52-Week Low | $230.30 | $259.02 |
Typical Hold Time | 85 Days | 97 Days |
Enterprise Value | $97.91B | $374.82B |
Dividend Yield | 2.13% | 2.5% |
Signals from Pluang's Aura AI — not financial advice
Royal Caribbean (RCL) trades at $282.26, showing minimal daily movement (-0.04%) amid strong fundamental performance. The stock maintains a bullish technical outlook with support at $279 and resistance at $284. Recent earnings beats in Q1 and Q2 2026, coupled with robust revenue growth from $8.8B in 2022 to $17.9B in 2025, highlight operational strength. The company's expansion into resort markets through the $3B Sandals acquisition adds growth diversification while analyst consensus remains positive with a $346.67 price target.
RCL presents a compelling growth story with expanding profit margins and strategic diversification, though elevated debt levels and fuel cost sensitivity pose moderate risks. The stock's current valuation at 17.38x P/E appears reasonable given 45.33% ROE and consistent earnings outperformance. Near-term catalysts include Q3 2026 earnings and continued execution on the Sandals integration, while macroeconomic pressures on travel demand represent the primary headwind.
UnitedHealth Group (UNH) trades at $375.98, showing minor daily weakness but maintaining a bullish technical signal. The company reported strong Q2 2026 earnings, beating estimates, and reaffirmed its full-year outlook. Revenue growth remains robust, though net margins have compressed from prior years. Analyst sentiment is overwhelmingly positive, with a consensus price target of $473.89 implying significant upside.
The outlook for UNH is favorable, driven by earnings momentum and strategic initiatives like AI investment. Key risks include regulatory pressures and medical cost trends. The stock presents a compelling opportunity for investors seeking exposure to a leading healthcare company with solid fundamentals and Wall Street support.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →